ESBATech develops the proprietary antibody fragment technology.
Business Model:
Revenue: $0
Employees: 51-200
Address: Wagistrasse 21
City: Schlieren
State: zurich
Zip: 8952
Country: CH
ESBATech develops the proprietary antibody fragment technology.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2002 | Series A | $0 |
InnoVentures Capital Partners LODH Immunology Fund Novartis Venture Fund InnoVentures Capital Partners LODH Immunology Fund Novartis Venture Fund |
8/2008 | Series B | 6 | $22M |
VI Partners SV Health Investors Novartis Venture Fund HBM Healthcare Investments AG Clarus Ventures BioMedPartners VI Partners SV Health Investors Novartis Venture Fund HBM Healthcare Investments AG Clarus Ventures BioMedPartners |
8/2006 | Series B | 6 | $41M |
SV Health Investors VI Partners Novartis Venture Fund BioMedPartners Clarus Ventures HBM Healthcare Investments AG SV Health Investors SV Health Investors VI Partners Novartis Venture Fund BioMedPartners Clarus Ventures HBM Healthcare Investments AG SV Health Investors |
5/2002 | Series A | 3 | $9M |
LODH Immunology Fund LODH Immunology Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|